Part One of our discussion with Dr. Michael Jewett, who is the Chairman of the Photodynamic Therapy Medical and Scientific Advisory Board of Theralase
Blader Cancer research is on the way with Theralase Technologies and Dr. Michael Jewett MD explains the status of this research which is continuing with…
Theralase Increases GBM Brain Cancer Survival by 925%
Here is the latest news from Theralse. We will be chatting with Roger shortly so if you have any questions please email or comment below….
Health Canada Grants Theralase ITA Approval
Health Canada Grants Theralase ITA Approval Toronto, Ontario – October 20, 2016, Theralase Technologies Inc. (“Theralase®” or the “Company”) (TLT:TSXV) (TLTFF:OTC), a leading biotech company…
Full interview with Roger White from Theralase
Here is the full interview with Theralase as featured on this week’s weekend show. If you have any follow up questions for Roger feel free…
DID THIS DROP IN GOLD RESULT IN A BUYING OPPORTUNITY?
Segment 1: We recap the moves in the US markets, gold and the USD to kick off this week’s show. Segment 2: The True Contrarian,…
Theralase Provides Update on ITA Application to Health Canada
Here is the latest news from Theralase. This release updated the status of the ITA filed with Health Canada for use of the Company’s “patent…
Theralase Increases Revenue 32% in 2H2016 Financials
The news out today from Theralase focuses on the Q2 2016 financials. You can read the summariezex results below. We will also be having Roger…
2016 Sprott Natural Resource Symposium
Segment 1: Brent Cook, Founder of Exploration Insights, outlines a couple companies he likes at the Sprott Natural Resource Symposium. Segment 2: Al and…
Theralase Files ITA Application to Health Canada
Theralase has now filed its ITA with Health Canada. Last week we said we would have Roger on the show but had to push that…
Clinical and Scientific Research Reports for Theralase
Al and I recently meet up with Roger when he was passing through Vancouver and had a great chat. In the conversation Roger pointed us…
Theralase Increases Revenue 11% in Q12016 Financials
For more information on the Q1 financial results click here to listen to an interview with Roger that was posted on the weekend. Here is…
Theralase Q1 financials and an update on the ITA
Roger White took time to update us on the progress of the upcoming ITA as well as the recently released financials. We discuss the sales…
Gold investment demand in the US is holding prices steady
Segment 1: Fund manager Dana Lyons provides his perspective on the potential of the US markets reaching all time highs. Segment 2: Chuck Provini, CEO…
Theralase Signs Clinical Research Agreement with University Health Network
Here is the latest news from Theralase. We will be having Roger White on the weekend show so tune in to find out what is…
Theralase Extends Research Agreement with University Health Network
Here is the latest news from Theralase. Reading through through the news real meat and bones is the following. “Theralase and UHN will work together…
Chris Temple – Special Report on Theralase
Our friend Chris Temple from The National Investor just released a special report on Theralase. Below is a brief summary and a link to download…
Update on Theralase TLC-2000 workforce and cancer division
Theralase (TLT:TSX.V) released news this morning so we brought CEO and President Roger White on the show for an update. We first get an update…
Theralase Research Published in International Peer-Reviewed Journal
Please let us know if you have any questions or comments for Roger White over at Theralase. Here is the Company’s most recent news. Toronto,…
An update from Roger White at Theralase
For those that are following the Theralase story you know that the Company has two divisions – a therapeutic laser division and a cancer division….
Theralase Provides Update on 2016 Strategic Initiatives
If you have any questions for Roger regarding Theralase please leave them in the comment section or email Cory directly at fleck@kereport.com. I am expecting…